Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
The Macmillan Support and Information Service celebrates its developments and achievements since opening ten years ago.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
The Secretary of State for Health and Social Care, The Rt. Hon. Sajid Javid MP visited the National Hospital for Neurology and Neurosurgery (NHNN), earlier this week (Wednesday 4 May 2022).
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
This page is for patients who have been referred on a suspected cancer pathway.
-
Robot-assisted surgery used to perform bladder cancer removal and reconstruction enables patients to recover far more quickly and spend significantly less time in hospital, concludes a trial led by UCLH, UCL and the University of Sheffield.
-
Matthew Fielden and Lillyanne Tran volunteer in the cognitive disorders outpatients’ clinic at the National Hospital for Neurology and Neurosurgery.
File results
-
FOI/2021/0367 - Religious accommodation
-
FOI/2021/0369 - Telecommunications
-
FOI/2021/0377 - Stonewall diversity applications
-
FOI/2021/0381 - International nursing agency spend
-
FOI/2021/0388 - Digital dictation/ Voice recognition system
-
FOI/2021/0409 - Service Manager for Paediatric Audiology department
-
FOI/2021/0413 - Service providers for patient, transport and private ambulance
-
FOI/2021/0414 - Cyber attacks
-
FOI/2021/0416 - Catering electronic meal ordering system
-
FOI/2021/0417 - A&E attendance for carbon monoxide poisoning